Neuland Laboratories (NSE:NEULANDLAB) Total Stockholders Equity : ₹12,827 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Neuland Laboratories Total Stockholders Equity?

Neuland Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹12,827 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Neuland Laboratories's Book Value per Share for the quarter that ended in Mar. 2024 was ₹999.78. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Neuland Laboratories's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.07.

Neuland Laboratories Total Stockholders Equity Historical Data

The historical data trend for Neuland Laboratories's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuland Laboratories Total Stockholders Equity Chart

Neuland Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

7,099.58

7,864.58

8,405.01

9,940.97

12,827.05

Neuland Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															9,940.97	-	11,327.82	-	12,827.05

Neuland Laboratories (NSE:NEULANDLAB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Neuland Laboratories's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(12827.048	-	0)	/	12.8299
	=	999.78

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Neuland Laboratories's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(412.656	+	541.24)	/	12827.048
	=	0.07

Neuland Laboratories Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Neuland Laboratories's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuland Laboratories (NSE:NEULANDLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (NSE:NEULANDLAB) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

524558:India

Address

Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033

Website

https://www.neulandlabs.com

Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (NSE:NEULANDLAB) Headlines

No Headlines